Wegovy without insurance typically costs around $1,350 per month at retail pharmacies, but several options can bring that number down significantly. The most straightforward path is Novo Nordisk’s own savings program, which drops the price to as low as $149 per month for the pill form or $199 for the pen, depending on your dose. Beyond that, a few other strategies can help manage the cost.
The Manufacturer Savings Program
Novo Nordisk offers a savings program through NovoCare that’s specifically available to uninsured and self-paying patients with a valid prescription. You don’t need commercial insurance to qualify. To enroll, you can visit the NovoCare website, text SAVE to 83757, or fill your prescription directly through NovoCare Pharmacy.
The pricing breaks down by formulation and dose:
- Wegovy pill: starts at $149 per month for new self-paying patients
- Wegovy pen: starts at $199 per month for new self-paying patients
- Wegovy HD pen: starts at $399 per month for new self-paying patients
To get these prices, you either fill through NovoCare Pharmacy directly or bring the savings offer to your local pharmacist. This is the single biggest discount available and should be the first thing you explore. The difference between $1,350 and $199 is substantial, and it requires nothing more than enrolling and having a prescription.
What Wegovy Costs Over Time
Wegovy uses a gradual dose escalation over roughly 17 weeks. You start at a low dose for the first month, then step up every four weeks until you reach your maintenance dose. The schedule looks like this: month one is the lowest dose, months two through four increase incrementally, and by month five you’re at the maintenance level of either 1.7 mg or 2.4 mg weekly.
This matters for budgeting because the starting doses are less expensive than the maintenance dose. If you’re using the manufacturer savings program, you’ll likely pay closer to $199 per month early on and $399 at the higher doses. Without any discount, you’re looking at roughly $1,330 to $1,460 per month at retail, depending on the pharmacy. Wegovy is a long-term medication, so plan for ongoing monthly costs rather than a one-time expense.
Using HSA or FSA Funds
If you have a Health Savings Account or Flexible Spending Account through an employer, you may be able to use those pre-tax dollars toward Wegovy. Eligibility varies by plan, so check with your benefits administrator before assuming coverage. Some plans require a letter of medical necessity from your doctor, particularly for weight management medications. Even if your health insurance doesn’t cover Wegovy, your HSA or FSA might still allow the expense, which effectively gives you a discount equal to your tax rate.
Why Compounded Versions Are Risky
Some compounding pharmacies sell cheaper versions of semaglutide (Wegovy’s active ingredient), and you’ll find them advertised online at a fraction of the brand-name cost. The FDA has issued clear warnings about these products. Compounded semaglutide is not FDA-approved, meaning no one has reviewed it for safety, effectiveness, or quality before it reaches you.
The specific concerns are serious. Some compounded products use salt forms of semaglutide, such as semaglutide sodium or semaglutide acetate, which are chemically different from what’s in the approved drug. The FDA has stated it doesn’t have information on whether these salt forms behave the same way in the body. Reports of dosing errors and adverse events requiring hospitalization have been linked to compounded versions. If you’re considering this route to save money, the manufacturer savings program is a far safer alternative at a comparable or lower price point.
Importing From Other Countries
Buying Wegovy from pharmacies in Canada or Mexico is another option people consider. The FDA has been actively cracking down on imported GLP-1 drug ingredients from unverified foreign sources. In early 2025, the agency created a “green list” import alert to stop potentially dangerous active ingredients from entering the U.S. Products from sources not on that list are subject to detention at the border.
Personal importation of prescription drugs is technically illegal under federal law, though enforcement has historically focused on bulk shipments rather than individual supplies. The practical risk is less about legal trouble and more about product quality. You have no guarantee that what arrives is the correct medication at the correct dose, stored at the correct temperature (semaglutide requires refrigeration).
When Generics Might Be Available
Novo Nordisk’s U.S. patent on semaglutide is set to expire in 2032. In October 2024, the company settled patent disputes with several major generic manufacturers, including Mylan (now Viatris), Sun Pharmaceutical, Dr. Reddy’s Laboratories, and Apotex. The terms of those settlements haven’t been fully disclosed, but they could potentially allow generic entry before the 2032 expiration date.
Outside the U.S., the timeline is faster. Novo Nordisk’s patent in China expires in 2026, and at least 15 Chinese pharmaceutical companies are developing generic versions, with 11 candidates in final-stage clinical trials. These won’t be available in the U.S. without FDA approval, but they signal that competition is coming. For now, though, a generic option in the U.S. is still years away.
Steps to Get Started
The practical path is straightforward. First, get a prescription from your doctor. Wegovy requires a BMI of 30 or higher, or 27 or higher with at least one weight-related health condition like high blood pressure or type 2 diabetes. Your doctor will confirm you’re a candidate and write the prescription.
Next, enroll in the NovoCare savings program before filling the prescription. You can do this online or by texting SAVE to 83757. Then either fill through NovoCare Pharmacy directly or bring the savings offer to a retail pharmacy. If you have an HSA or FSA, submit the receipt for reimbursement with pre-tax dollars. At $199 per month for the pen through the savings program, the cost is still significant but far more manageable than the $1,350 list price that stops most uninsured patients before they start.